Results 241 to 250 of about 3,775,993 (302)
Some of the next articles are maybe not open access.
Journal of Rheumatology, 2020
Objective To examine the comparative effects of biologic disease-modifying antirheumatic drugs (bDMARD) and tofacitinib against conventional synthetic DMARD (csDMARD) on incident cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA ...
G. Ozen, S. Pedro, K. Michaud
semanticscholar +1 more source
Objective To examine the comparative effects of biologic disease-modifying antirheumatic drugs (bDMARD) and tofacitinib against conventional synthetic DMARD (csDMARD) on incident cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA ...
G. Ozen, S. Pedro, K. Michaud
semanticscholar +1 more source
Chirality in antirheumatic drugs
The Lancet, 1991Use of chiral molecules in clinical practice may cause problems because different chiral forms of a drug (enantiomers) may have different biological activities--yet clinicians have little awareness of these risks. After discussion of the chemical conventions used to describe chirality, examples of the influence of chirality on the efficacy and toxicity
H. E. Howard-Lock +2 more
openaire +2 more sources
Antirheumatic Drugs in Pregnancy and Lactation
Seminars in Arthritis and Rheumatism, 2005To review the toxicity issues of commonly used antirheumatic drugs in pregnancy and lactation.A review of the medical literature using Medline database via Ovid was performed to identify the toxicities of antirheumatic drugs in pregnancy and lactation.Many rheumatologic diseases in women often first present during the childbearing years. In most cases,
Rama Bandlamudi +2 more
openaire +2 more sources
Drugs, 1976
Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy.
openaire +3 more sources
Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy.
openaire +3 more sources
Antirheumatic drugs in pregnancy and lactation
Baillière's Clinical Rheumatology, 1990The natural inclination of patients with rheumatic diseases wishing to become pregnant or to breast feed will be to take as few medications as possible. The guidelines outlined above can be used to balance the risk of drug effect on the fetus or neonate with the risk of inducing a flare in disease activity by stopping the drug.
Peter Brooks, Christopher J. Needs
openaire +3 more sources
Anti-inflammatory and Antirheumatic Drugs
Annals of Internal Medicine, 1981Excerpt Meclofenamate sodium (Meclomen; Parke-Davis, Morris Plains, New Jersey), a nonsteroidal anti-inflammatory agent of the fenamate group, has recently been approved by the U.S.
openaire +3 more sources
Disease-Modifying Antirheumatic Drugs
The Journal of Hand Surgery, 2009S T m f p c In B ri ef ISEASE-MODIFYING ANTIRHEUMATIC drugs (DMARDs) reduce the extent to which rheumatoid arthritis (RA) damages bone and carilage and reduce the disability that results from it. ll patients with RA should receive one or more MARDs as soon as the diagnosis of RA is estabished, because evidence suggests that the long-term utcome is ...
openaire +3 more sources
International Journal of Rheumatic Diseases, 2018
To identify the incidence and risk factors for hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients with resolved HBV receiving biological disease‐modifying antirheumatic drugs (bDMARDs).
Toshiyuki Watanabe +10 more
semanticscholar +1 more source
To identify the incidence and risk factors for hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients with resolved HBV receiving biological disease‐modifying antirheumatic drugs (bDMARDs).
Toshiyuki Watanabe +10 more
semanticscholar +1 more source
Evaluating the Antirheumatic Drugs
Annals of Internal Medicine, 1986Excerpt To the editor: The Food and Drug Administration (FDA) has just reported the completion of the first revision of guidelines for the clinical evaluation of nonsteroidal anti-inflammatory and ...
openaire +2 more sources
Disease-modifying antirheumatic drugs
Current Opinion in Rheumatology, 1997The case for early intervention with disease-modifying antirheumatic drugs is strengthened by published reports during the past year. These drugs include methotrexate, gold sulfasalazine, and antimalarial agents. The American College of Rheumatology issued guidelines for the management of rheumatoid arthritis and for monitoring the toxicity of ...
Bachmeier, Clarissa +7 more
openaire +5 more sources